Rashmika Patel
Overview
Explore the profile of Rashmika Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mikkilineni L, Natrakul D, Lam N, Manasanch E, Mann J, Weissler K, et al.
Mol Ther
. 2023 Dec;
32(2):503-526.
PMID: 38155568
Multiple myeloma (MM) is a rarely curable malignancy of plasma cells. MM expresses B cell maturation antigen (BCMA). We developed a fully human anti-BCMA chimeric antigen receptor (CAR) with a...
2.
Brudno J, Natrakul D, Karrs J, Patel N, Maass-Moreno R, Ahlman M, et al.
Blood Adv
. 2023 Nov;
8(3):802-814.
PMID: 37939262
New treatments are needed for relapsed and refractory CD30-expressing lymphomas. We developed a novel anti-CD30 chimeric antigen receptor (CAR), designated 5F11-28Z. Safety and feasibility of 5F11-28Z-transduced T cells (5F11-Ts) were...
3.
Brudno J, Lam N, Vanasse D, Shen Y, Rose J, Rossi J, et al.
Nat Med
. 2020 Apr;
26(5):803.
PMID: 32291416
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
4.
Brudno J, Lam N, Vanasse D, Shen Y, Rose J, Rossi J, et al.
Nat Med
. 2020 Jan;
26(2):270-280.
PMID: 31959992
Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are an effective treatment for B-cell lymphoma, but often cause neurologic toxicity. We treated 20 patients with B-cell lymphoma on a phase I,...
5.
Brudno J, Maric I, Hartman S, Rose J, Wang M, Lam N, et al.
J Clin Oncol
. 2018 May;
36(22):2267-2280.
PMID: 29812997
Purpose Therapies with novel mechanisms of action are needed for multiple myeloma (MM). T cells can be genetically modified to express chimeric antigen receptors (CARs), which are artificial proteins that...
6.
Day C, Patel R, Guillen C, Wardlaw A
Exp Lung Res
. 2009 May;
35(4):272-83.
PMID: 19415545
The chemokine receptor CXCR6 is highly expressed on lung-derived T cells compared to blood T cells, especially in inflammatory diseases characterised by T-cell migration to the lung. This suggests that...